By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Elite Pharmaceuticals, Inc. 

165 Ludlow Avenue

Northvale  New Jersey  07647  U.S.A.
Phone: 201-750-2646 Fax: 201-750-2755


SEARCH JOBS


Industry
Biotechnology






Company News
Elite Pharmaceuticals, Inc. (ELI) Granted New Patent For Abuse Deterrent Technology 6/16/2015 10:27:22 AM
Elite Pharmaceuticals, Inc. (ELI) Reports Financial Results For The Fiscal Year Ended March 31, 2015 6/16/2015 10:21:48 AM
Elite Pharmaceuticals, Inc. (ELI) To Host Conference Call And Webcast To Discuss Year End 2015 Financial Results On June 16, 2015 6/12/2015 7:21:51 AM
Elite Pharmaceuticals, Inc. (ELI) And Epic Pharma Enter Into A Sales And Distribution Licensing Agreement For Abuse-Deterrent ELI-200 6/9/2015 7:41:23 AM
Elite Pharmaceuticals, Inc. (ELI) Announces Launch Of Generic Hydroxyzine Tablets 4/21/2015 8:45:24 AM
Elite Pharmaceuticals, Inc. (ELI) Reports Financial Results For The Third Quarter Of Fiscal Year 2015 2/18/2015 8:19:17 AM
Elite Pharmaceuticals, Inc. (ELI) Provides Guidance On Phase III Study For ELI-200 2/18/2015 7:39:47 AM
Elite Pharmaceuticals, Inc. (ELI) To Host Quarterly Business Update Call On Wednesday, February 18, 2015 2/13/2015 7:48:33 AM
Elite Pharmaceuticals, Inc. (ELI) Announces First Shipment Of Generic Isradipine Capsules 1/16/2015 7:19:50 AM
Elite Pharmaceuticals, Inc. (ELI) Awarded Second Canadian Patent For Abuse Deterrent Drug Formulation 12/16/2014 7:46:43 AM
12345678910...
//-->